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Abstract
Background: A number of molecular tools have been developed to monitor the emergence and
spread of anti-malarial drug resistance to Plasmodium falciparum. One of the major obstacles to the
wider implementation of these tools is the absence of practical methods enabling high throughput
analysis. Here a new Zip-code array is described, called FlexiChip, linked to a dedicated software
program, which largely overcomes this problem.
Methods:  Previously published microarray probes detecting single-nucleotide polymorphisms
(SNP) associated with parasite resistance to anti-malarial drugs (ResMalChip) were adapted for a
universal microarray FlexiChip format. To evaluate the overall sensitivity of the FlexiChip package
(microarray + software), the results of FlexiChip were compared to ResMalChip microarray, using
the same extension probes and with the same PCR products. In both cases, sequence results were
used as gold standard to calculate sensitivity and specificity. FlexiChip results obtained with a set
of field isolates were then compared to those assessed in an independent reference laboratory.
Results: The FlexiChip package gave results identical to the ResMalChip results in 92.7% of
samples (kappa coefficient 0.8491, with a standard error 0.021) and had a sensitivity of 95.88% and
a specificity of 97.68% compared to the sequencing as the reference method. Moreover the method
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performed well compared to the results obtained in the reference laboratories, with 99.7% of
identical results (kappa coefficient 0.9923, S.E. 0.0523).
Conclusion: Microarrays could be employed to monitor P. falciparum drug resistance markers
with greater cost effectiveness and the possibility for high throughput analysis. The FlexiChip
package is a promising tool for use in poor resource settings of malaria endemic countries.
Background
Anti-malarial drugs play a pivotal role in malaria control,
but a limited number of new drugs are under develop-
ment. Resistance of malaria parasites to commonly used
anti-malarial drugs is also a global challenge. Thus, there
is a need to optimize the use of existing treatments and to
monitor the emergence and the spread of drug resistant
malaria parasites, in particular Plasmodium falciparum,
which is responsible for the vast majority of malaria
deaths [1-4]. Typing the known genetic drug resistance
markers is among the strategies currently used for moni-
toring the resistance of P. falciparum. Single nucleotide
polymorphisms (SNP) related to anti-malarial drug resist-
ance include five major genes: Pfdhfr  and  Pfdhps  for
pyrimethamine and sulphadoxine resistance, Pfcrt  and
Pfmdr1 for chloroquine resistance and recently, but not
yet confirmed by field studies, serca/atpase6 for artemisi-
nin resistance. Different molecular tools have been devel-
oped, including the PCR-RFLP method [5-8], real-time
PCR for assessing gene copy number [9], sequence analy-
sis [10], the heteroduplex tracking assay [11], and PCR-
amplification of the SNP containing fragments followed
by single base extension (SBE) of an elongation primer
with fluorescent ddNTP's [12].
DNA microarray-based SNP genotyping has been impor-
tantly developed over the past recent years. Surveying
SNPs is an important tool in epidemiological studies on
parasite resistance, but the currently available methods to
identify resistance all have important drawbacks, includ-
ing a limited focus on only the five mentioned genes and
absence of a high throughput format. Several systems
have been proposed [13,14], mainly based on PCR-ampli-
fication of the SNP containing fragments followed by SBE
of an elongation primer with fluorescent ddNTP's [15].
Recently, a genotyping array called ResMalChip has been
developed to monitor 34 SNPs in five genes of P. falci-
parum  that either confer or increase resistance to anti-
malarial drugs [16]. The ResMalChip method also has two
major drawbacks. First, the content of the microarray is
designed only for a specific objective (typing SNPs related
to resistance) in a specific organism. Therefore, the use of
this microarray for surveying other SNPs in any other gene
or organism requires a new array design and production.
This implies a large number of tests to adapt the system to
new markers. The design of the capture oligonucleotides
must be specific of the elongation primers and the exper-
imental conditions of hybridization must be compatible
with all the couples of capture oligo-elongation primers.
Moreover, no standard software has been developed for
data analysis. A new Zip-code array, called FlexiChip,
associated with a dedicated software has been designed to
address these problems (see Figure 1) [17]. This array con-
tains oligonucleotides (Zip-code) that are not comple-
mentary to any sequence in any known organism and
have been designed to have the same thermodynamic
properties. Therefore, various assays can be performed
using a single protocol from SNP discovery to hybridiza-
tion. The target probes contain the Zip-codes complemen-
tary sequences linked to the elongation primers. FlexiChip
can in principle be used to test any SNP. Furthermore, an
analysis algorithm based on a mixture model and allow-
ing accurate SNP identification has been developed. This
algorithm does not require any prior threshold determi-
nation and provides results in a simple Excel file format.
To evaluate the overall sensitivity of the FlexiChip package
(microarray + software), ResMalChip and FlexiChip data
sets were analysed with this software and tested against
sequence analysis. FlexiChip results were then compared
to results obtained with ResMalChip using the same PCR
products. For a set of 50 field isolates, FlexiChip results
were also compared to those obtained in another molec-
ular laboratory (MORU) acting as external quality control.
Methods
Clinical P. falciparum samples and DNA extraction
As part of the activities related to the assessment of drug
efficacy in uncomplicated malaria in Cambodia, 263 P.
falciparum  isolates were collected from consenting
patients from 2001 to 2004. Blood samples were kept at -
20°C at the Institut Pasteur du Cambodge until use. DNA
was extracted from blood samples using QIAmp® DNA
Mini Kit (Cat. No. 51306, QIAgen®, Germany), according
to the manufacturer's procedure. All studies were con-
ducted following good clinical practice, and ethical clear-
ance was obtained from the National Ethical Comity of
Cambodia.
Microarray design
Zip code design and microarray production
A Zip-code as used in the present study is defined as an
artificial sequence composed of 24 bases. All the Zip-
codes have similar melting temperature (Tm) values. A set
of 96 Zip-code of 24 mer oligonucleotides has beenMalaria Journal 2009, 8:229 http://www.malariajournal.com/content/8/1/229
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Schematic representation of the FlexiChip analysis method Figure 1
Schematic representation of the FlexiChip analysis method. A) SNPs are detected by Single Base Extension (SBE) 
using Sequenase and ddNTP labelled with Cyanine 3 or 5 using a specific probe that hybridizes one nucleotide upstream of the 
SNP site. B) Products of the SBE reaction are hybridized on FlexiChip by their Zip-code oligonucleotides. After washing and 
drying, the slides are scanned at two wave lengths. C) Analysis algorithm is based on a mixture model and allows accurate SNP 
identification. The results are stored in Excel file.
Microarray hybridization
(Sequenase reaction products are 
put down on the chip, incubated 1h 
at 50° C and then washed.)
Microarray allows to specifically demultiplex each reaction by Zip-code 
matching. cZip is bound to glass slides activated with aldehyde. 
FlexiChip Detection 
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designed using a dedicated algorithm developed in Visual
Basic (Microsoft®) (see Table S1 in Additional file 1). They
were tested to avoid self-pairing and hairpin formation
(FastPCR, Institute of Biotechnology, University of Hel-
sinki [18]). Reverse complement oligonucleotides (cZip)
were synthesized with an amino C-7 linker at the 3' end
used for its attachment to the slide. Then cZip were spot-
ted onto aldehydesilane coated slides with a 12-well for-
mat (AL MPX slides, Schott) using a VersArray
ChipWritterPro system (Bio-Rad Laboratories, Hercules,
CA). For spotting the cZip were resuspended at 50 micro-
molar in Phosphate buffer. FlexiChip spotting pattern of
the 96 cZip with Cy3, Cy5 anchor prelabeled oligonucle-
otide and six negative controls is presented in additional
figure 2A. Each oligonucleotide was spotted in triplicate.
A total of 12 independent hybridizations can be per-
formed in parallel on a single slide. ResMalChip arrays
were produced as described in [16].
Microarray validation
To evaluate possible cross-hybridization between Zip-
codes, each Zip-code associated with its primer was
labelled using the SBE protocol (see below) and hybrid-
ized one by one on the microarray. Cross-hybridization
was considered as significant when fluorescent average
signal intensity of non tested Zip-code spots was above
10% of the average positive signal of the tested Zip-code
spot. This was observed for only two spots out of 96 and
the corresponding two Zip-codes were discarded from the
analysis (see Table S1 in Additional file 1).
Microarray protocol (Figure 1)
DNA amplification to genotype SNPs associated with anti-malarial 
drug resistance
Ten nested PCR were used to amplify DNA sequences of
genes including SNPs associated with drug resistance as
reported previously[16]: pfmdr1 N86Y, Y184F, S1034C,
N1042D and D1246Y (two nested PCR); pfcrt  C72S,
K76T, H97Q, T152A, S163R, A220S, Q271E, N326D/S,
I356L/T and R371I (five nested PCR); pfdhfr A16V, N51I,
C59R, S108N/T and I164L (one nested PCR); pfdhps
S436A, A437G, K540E, A581G, A613T/S, I640F, and
H645P (one nested PCR); and pfATPase6 S538R, Q574P,
A623E, N683K, and S769N (one nested PCR).
Single base extension, SBE
Remaining free dNTP's were removed using a shrimp alka-
line phosphatase (SAP). Briefly, 5 μl of those ten nested
PCR products were mixed to 2 U of SAP (Amersham Bio-
sciences, Freiburg, Germany) and incubated for 1 h at
37°C. From each sample, two reactions were performed
using two combinations of Cy3 and Cy5 labelled ddNTP's
(Perkin Elmer, Schwerzenbach, Switzerland). Sequenase
(Termipol®, Solis, Tartu, Estonia) extension reaction, reac-
tion mixture and final denaturation were done for Res-
MalChip and FlexiChip as described by Crameri et al [16].
Extended primers with cyanine labelling were hybridized
onto the microarray. With this experimental design on
FlexiChip, two samples can be processed per spotting
area. As 40 positions are needed per sample, one set of
extension primers can be associated with Zip-codes 1 to
40 while the second set can be associated with Zip-codes
49 to 88 (remaining positions 41 to 48 and 89 to 96 were
not used).
Chip hybridization
Briefly, extended primers associated with a Zip-code were
resuspended in 6 μl of 20 × SSC (1× SSC = 0.15 M NaCl,
0.015 M sodium citrate, pH 7.2) and hybridized on the
array. Microarrays were then incubated during 60 min at
50°C, in a humid chamber and subsequently washed in 2
× SSC and 0,2% SDS for 20 min and in 2 × SSC for 20 min.
Microarrays were spun 5 min at 3000 g to dry. During
hybridization, extended primers linked with their specific
Zip-code were hybridized on the FlexiChip cZip pattern
(see Table S2B in Additional file 2).
Data acquisition
Hybridized microarrays were scanned at 635 nm and 532
nm using an Axon 4100A fluorescence scanner (Axon,
Bucher Biotec AG, Basel, Switzerland) and Axon GenePix®
Pro (version 6.0) software. The PMT (photomultiplier
tube) was 550 at 532 nm and 500 at 635 nm.
Data analysis and allele identification
All the data analyses were performed using the R software
[19] and packages. The allele identification algorithm was
written in R. It was applied independently on each array.
The aim of this algorithm is to classify each spot of the
array in either one of the "green", "red", or "indetermi-
nate" classes, and then convert the spot colour into the
corresponding SNP sequence. ResMalChip and FlexiChip
raw data were first corrected for background using the
limma package [20] (version 2.12.0) according to a two-
step procedure. A modified version of the "movingmin"
option of the background correction function ("called
"bgCorrect") was first applied to the data. This option
smoothes the background on the basis of a 3 × 3 moving
window. But unlike the original version, the modified ver-
sion does not substract the smoothed background. Then
the normexp procedure was applied. According to this
procedure, the observed signal is modeled as the convolu-
tion of a true signal and a background one, where the true
signal follows an exponential distribution and the back-
ground follows a Gaussian distribution.
This two-step process was derived because of a high back-
ground level observed with respect to the signal, especially
on ResMalChip data. Spots that still had a signal to noiseMalaria Journal 2009, 8:229 http://www.malariajournal.com/content/8/1/229
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ratio lower than one after background correction were
flagged "bg" (where "bg" stands for "background").
Data from negative and positive control spots were then
excluded from the data set. An intensity threshold IT was
computed on the remaining spots for each slide as the
median of pooled "red" and "green" intensities. A log2
ratio of the "red" intensity over the "green" intensity was
computed for each of the 1440 (three replicates of 40
SNPs spots for 12 samples) remaining spots.
A two-component Gaussian mixture model was fitted dif-
ferently to the ResMalChip and FlexiChip datasets. For the
ResMalChip dataset, a two-component Gaussian mixture
model was computed using the Mclust function from the
mclust package [21] with the modelNames parameter set to
"E" (Gaussian functions with same variance). These two
estimated Gaussian functions are estimates of the condi-
tional prior probability functions f(x/ω1) and f(x/ω2) that
describe the distribution of log ratios within the classes ω1
and ω2 (these two classes are respectively associated with
"green" and "red" spots). For the FlexiChip dataset, the
model was built in two steps. A first optimal mixture
model was computed using the Mclust function with
default parameters (modelNames = c("E","V")). In most
cases a three or more components mixture model was
obtained. To get a two-component mixture model these
components were grouped according to the sign (positive
or negative) of their mean and a mixture model was
derived from each of these two groups. These two "sub"-
models were then used as estimates of the conditional
prior probability functions (see Figure 2).
The remaining of the base-calling algorithm was then
identical for the datasets of both chips. Conditional pos-
terior probabilities P(ω1/x) and P(ω2/x) were computed
according to the Bayes theorem: P(ωi/x) = f(x/ωi). P(ωi)/
[f(x/ω1). P(ω1) + f(x/ω2). P(ω2)], i = 1,2
A third class called ω0 was created between ω1 and ω2. Its
boundaries were defined using a tunable parameter called
ambiguity rejection threshold and denoted Cr. This class
contained data from spots that had a probability lower
than Cr of belonging to one of the "red" and "green"
classes and was used to exclude data having a low proba-
bility of good classification, i.e. lower than Cr.
Each spot on the array was first classified within one of the
"green" (ω1)/"red" (ω2)/rejection (ω0)/weak signal/back-
ground (bg) classes according to the following decision
rules:
￿ P(ω1/x) > P(ω2/x) and P(ω1/x) > Cr and IS > IT and bg
= FALSE → d(x) = ω1
￿ P(ω2/x) > P(ω1/x) and P(ω2/x) > Cr and IS > IT and bg
= FALSE → d(x) = ω2
￿ max(P(ωi/x)) ≤ Cr, i = 1,2 and IS > IT and bg = FALSE
→ d(x) = ω0
￿ IS > IT and background = TRUE → d(x) = bg
￿ IS ≤ IT → d(x) = weak signal
where x is the log ratio associated with the spot, d(x) is the
decision associated with x, ISR and ISG are respectively the
"red" and "green" intensities measured on the spot, and IS
= max(ISR, ISG) is the maximum of both intensities for this
spot.
A final decision was taken for each SNP on the basis of its
three replicate spots as follows: if at least two of the three
replicates were belonging to the same class the SNP was
associated with this class, otherwise it was declared "inde-
terminate" and no further interpretation was performed.
Allele identification was done using a pre-defined table
that describes the expected signal for each allele of each
SNP (see Table 1). This table was fully derived from the
The mixture model (FlexiChip) Figure 2
The mixture model (FlexiChip). "Green": Gaussian com-
ponents of the "green" class, "red": Gaussian components of 
the "red class", thick "green": prior conditional probability 
density function f(x/ω1), thick "red": prior conditional proba-
bility density function f(x/ω2), dashed black: mixture density 
function f(x) = f(x/ω1)P(ω1) + f(x/ω2)P(ω2), "green" vertical 
line: lower limit of ω0, "red" vertical line: upper limit of ω0Malaria Journal 2009, 8:229 http://www.malariajournal.com/content/8/1/229
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design of the experiment. As an example, according to this
table a "red" signal (Cy5) is expected for spots associated
with the RES16 SNP if the allele in the studied sample is a
mutant, and a "green" signal (Cy3) otherwise. Three pos-
sible scenarios are encountered depending on the number
of different probes that were associated with the SNP. In
the first case, SNPs were represented by only one probe,
meaning that only two different alleles were known for
them. This was the most general case. Then, for SNPs that
had been classified in ω1 or ω2, allele identification came
straight from table 2. If a field sample was studied using
FlexiChip or ResMalChip and the hybridization signal for
the RES16 SNP was found to belong to the "red" class, the
Pfdhfr gene from this sample was identified as mutant at
position 16. The second scenario refers to SNPs that had
only two known alleles but were represented by two dif-
ferent probes on the slide, in order to strengthen the iden-
tification process. Then, if one of the probes was classified
as "weak signal" or "bg", the other probe result was taken
into account. If both probe signals were valid (d(x) = ω1
or d(x) = ω2), the coherence between the probes was
checked and in case of conflicting results the SNP was
declared "indeterminate". The last scenario refers to the
situation where more than two different alleles for a given
SNP exist. Thus, three or four different alleles must be dis-
criminated with two colours only. For these particular
SNPs, two different probes were designed and the corre-
sponding targets were labelled with two different combi-
nations of Cy3 and Cy5 labelled ddNTP's, as explained in
the experimental protocol section. For example, the posi-
tion 108 on gene Pfdhfr is represented by two probes on
the array, RES108 and RES108B. The first probe allows to
distinguish between the wild type allele and either
mutantA or mutantB. The second probe makes the differ-
ence between the mutantA and either wild type or
mutantB. In such a case, allele identification was resolved
according to the combination of both probe results. If one
or both probe signals were classified "weak signal", "bg"
or "indeterminate", the SNP was declared "indetermi-
nate", otherwise it was determined according to Table 1.
Mutually exclusive results for such two complementary
probes led the associated SNP to be declared "indetermi-
nate". As an example, this would be the case for the SNP
RES108, if both probes gave "red" signals.
Direct sequencing of PCR products
A set of samples was sequenced for Pfdhfr, Pfcrt, Pfmdr1
and PfATPase6.genes. PCR products were purified using a
P-100 Gel Fine solution (Biorad) and Multiscreen
MAVN45 kit system (Millipore). Sequencing reactions
were performed on both strands using internal primers
and ABI Prism BigDye Terminator chemistry. Sequencing
reactions were run on ABI Prism 3100 Genetic Analyzer
(Applied Biosystems) at the Plate-Forme Génomique of
Institut Pasteur in Paris, and analysed with Seqscape soft-
ware v.2.0. (Applied Biosystems).
External quality control
Fifty  P. falciparum isolates from Cambodia were tested
blindly in Mahidol Oxford Research Unit according to
their own protocols. Briefly five SNPs of Pfmdr1 (positions
86, 184, 1034, 1042 and 1246) and one SNP of Pfcrt genes
(position 76) were screened with restriction length poly-
morphism methods [6,7]. The Pfserca/Pfatpase6 gene was
sequenced (4068 bp). Results were compared to the four
SNPs tested with FlexiChip.
Results
Comparison between ResMalChip, FlexiChip and 
sequence results
ResMalChip
Twenty five gpr files generated by the Axon GenePix® Pro
software were analysed. They included data from 10520
SNPs corresponding to 263 samples tested for 40 posi-
tions on five genes. The best compromise between the
number of ambiguity rejections and the number of mis-
classifications was obtained with an optimal rejection
threshold of Cr = 0.2. On the 10520 SNPs data handled by
this algorithm, 1396 (13.3%) were classified as "weak sig-
nal" and 905 (8.6%) were rejected for ambiguity (they
belong to ω0, the intermediate class between the "red" and
"green" classes). Among the 1642 SNPs data which could
be compared to the sequence, 218 (13.3%) were classified
as "weak signal" and 109 (6.6%) "indeterminate" (incon-
sistency between replicates or ambiguity). Compared to
sequencing, considered the "gold standard", a good agree-
ment was found with 96.63% and 95.74% for sensitivity
and specificity respectively.
FlexiChip
Six gpr files were analysed corresponding to 5000 SNPs
data from 125 samples (part of the previous 263 samples
analysed within ResMalChip) tested for 40 positions on
five genes. The optimal rejection threshold value Cr was
also 0.2. On 5000 SNPs analysed by the algorithm, 332
(6.6%) were classified as "weak signal" and 222 (4.4%)
"indeterminate", i.e. two to three times less than with the
ResMalChip array. Among the 1215 SNPs data for which
the sequences were available, 28 (2.3%) and 38 (3.1%)
were respectively considered as "weak signal" and "inde-
terminate". Sensitivity and specificity were 95.88% and
97.68% respectively.
ResMalChip versus FlexiChip
A total of 3,078 SNP data corresponding to 81 samples
and 38 positions on five genes were available in both Res-
MalChip and FlexiChip datasets. Among them, 2195
SNPs data were interpretable ("red" or "green" signal)
with both techniques. An identical diagnosis was found
for 2,034 (92.7%) of the SNP data (kappa coefficient
0.8491 with a standard error of 0.0213). When the results
on a gene-by-gene basis were considered (Table 2), a very
good agreement was found for dhfr, crt, atpase and mdr1Malaria Journal 2009, 8:229 http://www.malariajournal.com/content/8/1/229
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gene. The main discrepancies were observed for the dhps
gene.
Comparison between FlexiChip and Mahidol-Oxford 
Research Unit (MORU) results
Fifty isolates were tested for eight SNPs in parallel in
MORU with standard methods and with the FlexiChip.
Among the 400 SNP data, 34 (8.5%) were classified as
"weak signal" or "indeterminate". Among the 366 remain-
ing SNP data, results were identical with both techniques
in 365 cases (99.7% specificity, 91.5% sensibility, kappa
coefficient 0.9923 with a standard error of 0.0523).
Discussion
Molecular tools are essential for monitoring emergence
and spread of anti-malarial drug resistance and are part of
strategies described by the World Wide Anti-malarial
Resistance Network (WWARN) consortium [22,23]. Cor-
relation of molecular markers with in vivo and in vitro
drug resistance has been clearly established for dhfr/dhps
(sulphadoxine-pyrimethamine) and pfcrt  (chloroquine)
mutations,  mdr1  (chloroquine, mefloquine) and cyto-
chrome b (atovaquone). The microarray method described
in this paper enables to implement molecular monitoring
on a large scale because of the possibility to automatically
analyse and interpret the results.
Table 1: Expected spot signals for SNP positions processed by the algorithm (Results are given as a comparison with 3D7 genotype; 
WT = Wild type, MUT = Mutation) 
Gene Name SNP code SNP name Cy3 "green" signal Cy5 "red" signal Sequence
Pfdhfr RES16 16 WT MUT *
Pfdhfr RES51 51 WT MUT *
Pfdhfr RES59 59 WT MUT *
Pfdhfr RES108 108 MutA or MutB WT *
Pfdhfr RES108B 108B WT or MutA MutB *
Pfdhfr RES164 164 WT MUT *
Pfdhfr RES164B 164B WT MUT *
Pfdhps RES436 436 WT Mut1
Pfdhps RES437 437 MUT WT
Pfdhps RES540 540 WT MUT
Pfdhps RES581 581 WT MUT
Pfdhps RES613 613 MutA WT or MutB
Pfdhps RES613B 613B WT or MutA MutB
Pfdhps RES640 640 MUT WT
Pfdhps RES645 645 MUT WT
Pfmdr1 RES86 86 WT MUT *
Pfmdr1 RES184 184 WT MUT *
Pfmdr1 RES1034 1034 WT MUT *
Pfmdr1 RES1042 1042 MUT WT *
Pfmdr1 RES1246 1246 MUT WT *
Pfcrt RES72 72 MUT WT *
Pfcrt RES74 74 MUT WT *
Pfcrt RES75 75B1 WT MUT *
Pfcrt RES76 76 WT MUT *
Pfcrt RES97 97 WT MUT *
Pfcrt RES152 152 WT MUT
Pfcrt RES163 163 WT MUT
Pfcrt RES220 220 MUT WT
Pfcrt RES271 271 WT MUT
Pfcrt RES326 326 WT Mut1
Pfcrt RES326B 326B Mut2 WT
Pfcrt RES356 356 WT Mut1
Pfcrt RES356B 356B WT Mut2
Pfcrt RES371 371 MUT WT
PfATPase6 RES538 538 WT MUT *
PfATPase6 RES574 574 MUT WT *
PfATPase6 RES623 623 WT MUT *
PfATPase6 RES683 683 WT MUT *
PfATPase6 RES769 769 MUT WT *
PfATPase6 RES769B 769B WT MUT *
(Mutations with * were sequenced and used for our comparison with the result of the two arrays).Malaria Journal 2009, 8:229 http://www.malariajournal.com/content/8/1/229
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The aim of this project was to evaluate the flexible micro-
array under practical conditions using field isolates, in
which multiple infections are frequently observed. With-
out any dye bias on the array, spots associated with mixed
alleles should exhibit a "yellow" signal corresponding to
a mix between red and green signals. In the framework of
the proposed mathematical model, these spots should
then fall in the intermediate class ω0. Thus, this class
would be used to detect mixed infections instead of inde-
terminate ones. However, this mathematical property of
the model could not be fully validated for several reasons.
First, in the current study some SNPs showed no polymor-
phism in the processed samples. Indeed, field samples
were sequenced for 20 SNPs out of 40 that were geno-
typed on the array. Among these 20 sequenced SNPs, only
five showed polymorphism, with only one having both
alleles in (almost) equal amount. Therefore, any dye bias
on the signals measured on FlexiChip cannot be excluded,
it would prevent mixed signals to behave as expected by
the mathematical model. Second, the gold standard used
to compare FlexiChip results with is sequencing. This
method may not be the best one in the case of mixed alle-
les because chromatograms may be difficult to interpret,
leading to erroneous sequences. The parameters of the
mathematical model are derived on an array-by-array
basis in order to adapt to possible technical variabilities
between arrays. So they depend also on the proportion of
single and mixed infections that are hybridized on the
array. As most of the field samples analysed in this study
were not polymorphic, the model behaviour in the case of
a majority of mixed alleles cannot be predicted. But it is
doubtless that it will have to be adapted to match the data
distribution in that particular case. Finally, the actual
design of FlexiChip makes it non exhaustive, as the use of
two colours only for most of the monitored SNPs makes
it unable to detect all the mutations The use of two mix
combinations for the SNP located at position 108 on the
pfdhfr gene led to a good classification rate of 100%. It is
clear that extending the concept to the whole set of SNPs
would increase the reliability of the base calling process,
even in the case of mixed infections. Nevertheless, Res-
MalChip microarray has already been used in an environ-
ment of complex malaria infections like [24].
Combined with the FlexiChip microarray, the software
provided a sensitivity and specificity of 95.88% and
97.68% respectively when compared to sequencing as the
reference method. Moreover, the method performed well
when compared to results obtained in a reference labora-
tory, with 99.7% concordance (kappa coefficient 0.9923
with a standard error of 0.0523).
The proposed package can be useful for epidemiological
surveys and can give information on the dynamics of
emergence and spread of genetic markers in time and/or
in space. However, the method cannot be used as an
immediate diagnostic tool for individual samples,
because the format requires a high number of samples
tested at one time to be cost effective.
In contrast to previous methods, FlexiChip is no longer
dedicated to a single set of genes and/or organisms.
Thanks to its flexibility, integration of new SNPs linked to
anti-malarial drug resistance is made simpler and adjunc-
tion of species identification is now possible. It is easy to
adapt to other loci and in particular for SNP detection of
other organisms like HIV or Multi Drug Resistant Tuber-
culosis strains. Moreover, FlexiChip package is ready for
use and adaptable to large scale studies to validate new
molecular marker candidates.
Concluding remarks
One of the major obstacles for implementation of molec-
ular monitoring of resistance lies in the absence of practi-
cal tools for high throughput analysis. Universal
microarrays such as FlexiChip could help to change this,
as they are adapted to processing of numerous samples
and easily adaptable to new markers. Furthermore, they
are well suited for molecular biology laboratories from
endemic countries, which need a robust and simple tool
that could be easily adapted to a specific epidemiological
situation.
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List of cZip Codes spotted on FlexiChip. Table S1: List of cZip Codes 
spotted on FlexiChip. *: discarded from the analysis (number 49 and 61)




Scheme of the spotted oligonucleotides and expected hybridization. 
Table S2: Scheme of the spotted oligonucleotides and expected hybridiza-
tion. A) Spotting pattern of cZip on FlexiChip (Neg = Spot of water; Cy3 
and Cy5 = anchor oligonucleotides prelabeled with Cy3 or Cy5). B) 
Example of a FlexiChip within SNPs associated with parasite resistance to 
anti-malarial drugs used (blue and white areas correspond to the two sam-
ples that can be diagnosed at the same time; zip41 to 48 and 89 to 96 are 
not used on this microarray)
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